Twin Tree Management LP Has $6.09 Million Stake in Align Technology, Inc. $ALGN

Key Points

• Twin Tree Management LP significantly increased its stake in Align Technology, Inc. by 611.3% during Q2, now owning over $6 million worth of shares.
• Align Technology’s stock has recently faced rating adjustments, with Morgan Stanley downgrading its price target from $249 to $154 and several analysts issuing "hold" or "sell" ratings.
• The company reported a revenue decline of 1.6% year-over-year, alongside a share repurchase plan worth $200 million signaling potential undervaluation of its stock.

Twin Tree Management LP lifted its stake in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 611.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,177 shares of the medical equipment provider's stock after acquiring an additional 27,653 shares during the period. Twin Tree Management LP's holdings in Align Technology were worth $6,092,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Applied Fundamental Research LLC acquired a new stake in Align Technology in the second quarter valued at approximately $5,925,000. Envestnet Portfolio Solutions Inc. lifted its holdings in Align Technology by 4.5% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 2,372 shares of the medical equipment provider's stock worth $449,000 after acquiring an additional 102 shares during the period. Sequoia Financial Advisors LLC boosted its position in Align Technology by 153.2% in the second quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the medical equipment provider's stock worth $650,000 after purchasing an additional 2,077 shares during the last quarter. M.E. Allison & CO. Inc. grew its stake in Align Technology by 19.5% in the 2nd quarter. M.E. Allison & CO. Inc. now owns 1,750 shares of the medical equipment provider's stock valued at $331,000 after purchasing an additional 285 shares during the period. Finally, CWM LLC boosted its holdings in shares of Align Technology by 43.7% in the 2nd quarter. CWM LLC now owns 13,271 shares of the medical equipment provider's stock worth $2,513,000 after buying an additional 4,034 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ALGN has been the topic of several research reports. Morgan Stanley reaffirmed an "equal weight" rating and issued a $154.00 price objective (down previously from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Zacks Research raised shares of Align Technology from a "strong sell" rating to a "hold" rating in a report on Tuesday, September 30th. Leerink Partners reduced their price objective on Align Technology from $188.00 to $172.00 and set an "outperform" rating for the company in a report on Tuesday. Evercore ISI lowered their target price on Align Technology from $170.00 to $160.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 8th. Finally, Weiss Ratings cut Align Technology from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, Align Technology currently has an average rating of "Hold" and a consensus target price of $187.67.

Align Technology Stock Down 1.0%

Shares of ALGN opened at $128.43 on Thursday. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $246.19. The stock has a market cap of $9.31 billion, a PE ratio of 21.66, a P/E/G ratio of 1.47 and a beta of 1.70. The business's 50-day moving average price is $135.08 and its 200-day moving average price is $163.69.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing the consensus estimate of $2.57 by ($0.08). Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The firm had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1.06 billion. During the same period in the prior year, the firm posted $2.41 EPS. Align Technology's revenue was down 1.6% on a year-over-year basis. Align Technology has set its Q3 2025 guidance at EPS. Analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology announced that its Board of Directors has authorized a share repurchase plan on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Insider Transactions at Align Technology

In other Align Technology news, CEO Joseph M. Hogan bought 7,576 shares of Align Technology stock in a transaction that occurred on Friday, August 1st. The stock was acquired at an average cost of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the transaction, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.66% of the company's stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.